HCA Healthcare (HCA) Q2 2026: Revenue $20.2B +8.7%, Operating Cash Flow -44%, Annual Guidance Cut
HCA Healthcare, the largest for-profit hospital chain in the United States, posted Q2 2026 revenue of $20.230 billion (+8.7% year over year), net income attributable to the company of $1.699 billion (+2.8%, diluted EPS $7.62), and adjusted EBITDA of $4.027 billion (+4.6%) (per the company's earnings press release). Behind the headline growth, two opposing forces are in direct conflict: the one-time revenue recognition tied to Florida's Directed Payments Program (DPP) and the 23.3% surge in uninsured admissions triggered by the expiration of the Enhanced Premium Tax Credit (EPTC). Operating cash flow on a standalone Q2 basis collapsed 44.5%, from $4.210 billion to $2.335 billion (the six-month cumulative figure fell 25.8%, from $5.861 billion to $4.349 billion), and accounts receivable swelled by $1.414 billion over six months, raising collection risk.
Most notably, the company lowered its 2026 full-year guidance alongside the results — net income from $6.495–7.035 billion to $6.300–6.700 billion, adjusted EBITDA from $15.55–16.45 billion to $15.40–16.10 billion, and diluted EPS from $29.10–31.50 to $28.70–30.50. The real story this quarter lies not in the income statement but in the cash flow statement, the balance sheet, and a forecast that management itself has marked down.
1. Consolidated Balance Sheet Analysis
1-1. Key Asset Line Items (Dec 31, 2025 → Jun 30, 2026)
| Item | Prior Period ($ millions) | Current Period ($ millions) | Change | Interpretation |
|---|---|---|---|---|
| Cash and cash equivalents | 1,040 | 1,013 | -2.6% | Defended by new bond issuance despite $3.6B in share repurchases |
| Accounts receivable | 10,867 | 12,281 | +13.0% | Uncollected Florida DPP and Medicaid supplemental payment accruals — direct cause of operating cash decline |
| Inventories | 1,652 | 1,662 | +0.6% | Essentially flat — no material interpretation warranted |
| Property, plant & equipment (net) | 31,141 | 31,816 | +2.2% | 6M capex of $2.350B (vs. $2.167B prior year, +8.4%) — ongoing growth and facility investment |
| Goodwill and intangible assets | 10,293 | 10,662 | +3.6% | Reflects $386M acquisition of non-hospital healthcare assets |
Key takeaway: The 13.0% rise in accounts receivable (+$1.414 billion) reflects retroactive Florida DPP revenue of $1.372 billion (of which approximately $980 million relates to pre-2026 periods) that has been recognized as revenue but not yet collected in cash. Medicaid revenue for the quarter accordingly surged from $1.440 billion to $2.789 billion, +93.7%. In other words, a substantial portion of this quarter's revenue growth stems from one-time catch-up recognition tied to CMS (Centers for Medicare & Medicaid Services) approval timing, and this contribution will diminish in subsequent quarters. (All figures per the Form 10-Q text and notes.)
